Effects of Glaucoma Medications on Eye Cells
Author Information
Author(s): Ammar David A. Kahook, Malik Y. Kahook
Primary Institution: University of Colorado Hospital Eye Center, University of Colorado Denver, Department of Ophthalmology
Hypothesis
The study investigates the effects of different preservatives in glaucoma medications on human trabecular meshwork cells.
Conclusion
Replacing benzalkonium chloride with polyquad in glaucoma medications improves the viability of trabecular meshwork cells.
Supporting Evidence
- BAK reduced TM cell viability in a dose-dependent manner.
- Travoprost with timolol had more live cells than latanoprost with timolol when preserved with BAK.
- Replacing BAK with PQ significantly increased the number of live TM cells.
Takeaway
This study found that using a different preservative in eye drops can help keep eye cells healthier.
Methodology
The study tested various glaucoma medications on cultured human trabecular meshwork cells to assess cell viability and apoptosis.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website